Seres Therapeutics (MCRB) Misses Q1 EPS by 28c

Seres Therapeutics (NASDAQ: MCRB) reported Q1 EPS of ($0.28). Revenue for the quarter came in at $360 thousand.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

You May Also Be Interested In

• Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• Li Auto reports 37,679 vehicle deliveries in August 2026